Afya (NASDAQ:AFYA) Stock Rating Upgraded by Zacks Research

Afya (NASDAQ:AFYA – Get Free Report) was upgraded by investment analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a report issued on Monday, Zacks reports.

Several other equities analysts have also recently weighed in on AFYA. Wall Street Zen upgraded Afya from a “hold” rating to a “buy” rating in a research note on Saturday, September 5th. Bank of America reissued a “neutral” rating on shares of Afya in a research report on Thursday, June 11th. Weiss Ratings downgraded shares of Afya from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday, July 31st. JPMorgan Chase & Co. decreased their price objective on shares of Afya from $21.50 to $21.00 and set a “neutral” rating for the company in a research note on Monday, June 22nd. Finally, Bradesco Corretora raised shares of Afya to an “outperform” rating and set a $17.00 target price on the stock in a research report on Thursday, September 24th. Two research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $17.25.

Check Out Our Latest Research Report on AFYA

Afya Stock Performance

Shares of AFYA opened at $13.91 on Monday. The company has a debt-to-equity ratio of 0.39, a quick ratio of 2.20 and a current ratio of 2.20. The stock has a 50 day moving average price of $13.78 and a two-hundred day moving average price of $14.26. The firm has a market capitalization of $1.30 billion, a P/E ratio of 8.48, a P/E/G ratio of 1.49 and a beta of 0.34. Afya has a 52 week low of $11.62 and a 52 week high of $16.16.

Afya (NASDAQ:AFYA – Get Free Report) last posted its earnings results on Friday, August 14th. The company reported $0.43 earnings per share for the quarter, beating analysts’ consensus estimates of $0.40 by $0.03. The company had revenue of $187.80 million for the quarter, compared to analyst estimates of $189.62 million. Afya had a return on equity of 17.58% and a net margin of 20.55%. Equities analysts forecast that Afya will post 1.86 earnings per share for the current fiscal year.

Insider Transactions at Afya

In related news, insider Santos Welder Ferreira sold 4,161 shares of the firm’s stock in a transaction dated Monday, October 5th. The shares were sold at an average price of $13.30, for a total transaction of $55,341.30. Following the completion of the sale, the insider owned 35,000 shares in the company, valued at approximately $465,500. This trade represents a 10.63% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the stock. Public Employees Retirement System of Ohio bought a new stake in shares of Afya in the 2nd quarter worth approximately $67,000. Engineers Gate Manager LP purchased a new position in shares of Afya during the 2nd quarter valued at $325,000. Finally, Banco BTG Pactual S.A. bought a new stake in Afya in the 4th quarter valued at about $462,000. 88.02% of the stock is owned by institutional investors.

Afya Company Profile

(Get Free Report)

Afya Limited (NASDAQ: AFYA) is a Brazil-based medical education and health technology company. The company provides education and professional development for physicians and other healthcare professionals, with activities spanning undergraduate medical programs, medical residency preparation, specialization courses, continuing medical education and digital learning services.

Afya also develops technology-enabled products designed to support healthcare professionals throughout their careers.

See Also

Analyst Recommendations for Afya (NASDAQ:AFYA)

Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.